NCT00898235 Collection of Samples and Clinical Data From Patients With Amyloid Diseases
| NCT ID | NCT00898235 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Boston Medical Center |
| Condition | Multiple Myeloma |
| Study Type | OBSERVATIONAL |
| Enrollment | 10,000 participants |
| Start Date | 2000-01 |
| Primary Completion | 2040-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10,000 participants in total. It began in 2000-01 with a primary completion date of 2040-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
RATIONALE: Collecting and storing samples of blood, urine, tissue and data from patients with amyloid diseases to test in the laboratory may help the study of this disease in the future. PURPOSE: This research study is collecting samples from patients with amyloid diseases
Eligibility Criteria
Inclusion Criteria: DISEASE CHARACTERISTICS: * Diagnosis or suspicion of amyloidosis PATIENT CHARACTERISTICS: * Referred to the Amyloid Treatment and Research Center at Boston University Medical Center PRIOR CONCURRENT THERAPY: * Not specified Exclusion Criteria: None
Contact & Investigator
Vaishali Sanchorawala, MD
PRINCIPAL INVESTIGATOR
Boston Medical Center
Frequently Asked Questions
Who can join the NCT00898235 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Multiple Myeloma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT00898235 currently recruiting?
Yes, NCT00898235 is actively recruiting participants. Contact the research team at vaishali.sanchorawala@bmc.org for enrollment information.
Where is the NCT00898235 trial being conducted?
This trial is being conducted at Boston, United States.
Who is sponsoring the NCT00898235 clinical trial?
NCT00898235 is sponsored by Boston Medical Center. The principal investigator is Vaishali Sanchorawala, MD at Boston Medical Center. The trial plans to enroll 10,000 participants.